National assembly may revise pharmaceutical affairs law in Aug.

Published: 2000-07-31 16:22:00

Updated: 2000-07-31 16:22:00

The revised bill of pharmaceutical affairs law failed to pass through the latest plenary session of the National Assembly due to an extreme political confrontation between the ruling and the opposite party. The revised supplementary budget bill including the medical reform financial fund also fai...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK